Skip to main content

ALPHA Project Publication and Articles

Below are links to publications and articles developed through the work of The ALPHA Project to address critical barriers toward improving outcomes in lupus. 

medical-clipboard
Meeting Report: The ALPHA Project: A Stakeholder Meeting on Lupus Clinical Trial Outcome Measures and the Patient Perspective

Lupus Science & Medicine, February 14, 2023

medical-clipboard
Lupus Spectrum Ambiguity Has Long-term Negative Implications for Patients

Lupus Science & Medicine, January 11, 2023

medical-clipboard
Establishing Consensus and Prioritisation of Global Community Recommendations

Lupus Science & Medicine, January 29, 2021

medical-clipboard
Establishing Consensus Understanding of the Barriers to Drug Development in Lupus

Therapeutic Innovation & Regulatory Science, March 6, 2020

medical-clipboard
5 Challenges in the Treatment & Diagnosis of Lupus

The Rheumatologist, February 13, 2020

medical-clipboard
Addressing Barriers in SLE Diagnosis, Care, and Access to Treatment

Rheumatology Advisor, August 27, 2019

medical-clipboard
Addressing a Critical Need for the Global Lupus Community

Applied Clinical Trials, August 22, 2019

medical-clipboard
International Lupus Community Reaches First-Ever Agreement on Treatment Barriers

Healthcare Purchasing News, July 31, 2019

medical-clipboard
Lupus Heterogeneity Tops List of Global Barriers to Advancing Care

Healio Rheumatology, July 31, 2019

medical-clipboard
Lupus Community Tackles Treatment & Clinical Trial Barriers

Clinical Leader, July 29, 2019

medical-clipboard
Global consensus building and prioritisation of fundamental lupus challenges: the ALPHA project

Lupus Science & Medicine, July 19, 2019

medical-clipboard
Diversity of Signs and Symptoms Identified as Major Challenge

Symptoms of lupus may look similar to symptom associated with other medical conditions and vary a lot from patient to patient.

medical-clipboard
Addressing Top Lupus Drug Development Barriers

People with lupus often use treatments not approved for lupus, making it difficult to get them covered by insurance and to deal with their side effects.

medical-clipboard
Tackling Lupus Clinical Care Barriers

There is no one test and no set criteria of signs and symptoms for lupus, placing diagnosis and treatment is far behind other autoimmune diseases.

medical-clipboard
ALPHA Project: Addressing Challenges in Access to Care

Access to care is important for promoting and maintaining one’s health, as well as preventing or reducing long term disability from diseases, such as lupus.